#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
Tag: otolaryngology
#VisualAbstract: Primary surgical treatment is effective for human papillomavirus-negative oropharyngeal carcinoma with T1-2 staging
Click to read this study in Otolaryngology - Head and Neck Surgery.
#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Dose-escalated intensity-modulated radiotherapy does not improve survival for patients with laryngeal or hypopharyngeal cancers
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer
Click to read the study in JAMA Oncology.
#VisualAbstract: Development of pharyngocutaneous fistulas after salvage laryngectomy is associated with an increased risk of distant metastasis
Click to read the study in JAMA Otolaryngology Head & Neck Surgery.
#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Click to read the study in Nature Communications.
Adjuvant metronomic capecitabine improves survival in patients with locoregionally advanced nasopharyngeal carcinoma
1. Adjuvant capecitabine resulted in fewer instances of disease recurrence and death compared to standard therapy. 2. Overall and failure-free ...
